Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Pengo

Showing results (61-70 of 166) with videos related to

Pageof 17
Sort By:
Lupus|April 7, 1999
[Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseasesA Biasiolo, P Rampazzo, T Brocco, et al.
Blood|November 26, 1999
Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activityV Pengo, T Brocco, A Biasiolo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2018
Laboratory criteria for antiphospholipid syndrome: replyK M J Devreese, T L Ortel, V Pengo, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic diseaseA Girolami, V Pengo, G Cappellato, et al.
Minerva Cardioangiologica|June 1, 1984
[Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin]R Russo, P Prandoni, V Pengo, et al.
European Journal of Cancer|February 1, 1980
Radioiodinated fibrinogen in the evaluation of patients with osteosarcomaD Casara, G Cartel, S Costa, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1985
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosisA Girolami, S Antico, V Pengo, et al.
Giornale Italiano Di Cardiologia|December 1, 1989
[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs]V Pengo, P Peruzzi, A Marzari, et al.
International Journal of Cardiology|June 23, 2012
Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndromeE Falcinelli, M Pompili, V Pengo, et al.
Platelets|March 8, 2017
The role of platelets in antiphospholipid syndromeG Baroni, A Banzato, E Bison, et al.
Pageof 17

Showing results (61-70 of 166) with videos related to

Sort By:
Pageof 17
Lupus|April 7, 1999
[Anti-beta2 glycoprotein I-beta2 glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseasesA Biasiolo, P Rampazzo, T Brocco, et al.
Blood|November 26, 1999
Procoagulant effect of anti-beta2-glycoprotein I antibodies with lupus anticoagulant activityV Pengo, T Brocco, A Biasiolo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 15, 2018
Laboratory criteria for antiphospholipid syndrome: replyK M J Devreese, T L Ortel, V Pengo, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1983
Antithrombin III Padua: a "new" congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic diseaseA Girolami, V Pengo, G Cappellato, et al.
Minerva Cardioangiologica|June 1, 1984
[Effect of the degree of anticoagulation on the plasma levels of beta-thromboglobulin in patients with heart valve prostheses treated with warfarin]R Russo, P Prandoni, V Pengo, et al.
European Journal of Cancer|February 1, 1980
Radioiodinated fibrinogen in the evaluation of patients with osteosarcomaD Casara, G Cartel, S Costa, et al.
Folia Haematologica (Leipzig, Germany : 1928)|January 1, 1985
The use of laser-nephelometry in evaluating fibrinogenaemia in patients with hepatocarcinoma and cirrhosisA Girolami, S Antico, V Pengo, et al.
Giornale Italiano Di Cardiologia|December 1, 1989
[Advantages of a cardiologic ambulatory care facility specifically organized for patients undergoing treatment with oral anticoagulant drugs]V Pengo, P Peruzzi, A Marzari, et al.
International Journal of Cardiology|June 23, 2012
Higher levels of plasma matrix metalloproteinase-2 are associated with a significantly increased risk of arterial thrombosis in patients with the antiphospholipid syndromeE Falcinelli, M Pompili, V Pengo, et al.
Platelets|March 8, 2017
The role of platelets in antiphospholipid syndromeG Baroni, A Banzato, E Bison, et al.
Pageof 17